Blood:在成人T细胞白血病/淋巴瘤中,IRF4和NF-κB形成一个前馈回路调控基因表达

2020-02-03 QQY MedSci原创

中心点:在ATL细胞,IRF4和NF-κB形成一个前馈回路,协同调控基因的表达。IRF4和NF-κB结合在超级增强子丰富区域,调控重要致癌基因表达,包括MYC、CCR4和BIRC3。摘要:成人T细胞白血病/淋巴瘤(ATL)是一种来源于成熟CD4+T淋巴细胞的高侵袭性的恶性血液病。近期,研究人员发现,ATL细胞转录调控网络由两个致癌转录因子(IRF4和NF-κB)驱动。原发性ATL样本的基因表达谱显

中心点:

在ATL细胞,IRF4和NF-κB形成一个前馈回路,协同调控基因的表达。

IRF4和NF-κB结合在超级增强子丰富区域,调控重要致癌基因表达,包括MYC、CCR4和BIRC3。

摘要:

成人T细胞白血病/淋巴瘤(ATL)是一种来源于成熟CD4+T淋巴细胞的高侵袭性的恶性血液病。近期,研究人员发现,ATL细胞转录调控网络由两个致癌转录因子(IRF4和NF-κB)驱动。

原发性ATL样本的基因表达谱显示,IRF4基因在ATL细胞中的表达高于正常T细胞。染色质免疫沉淀测序分析显示,IRF4结合区域在超级增强子中比在典型增强子中更常见。

NF-κB也结合在IRF4-结合的调控元素上,形成一个连贯的前馈回路,协同调节基因参与T细胞的功能和发展。此外,在ATL细胞中,IRF4和NF-κB还调控几个与ATL超级增强子相关的癌基因,包括MYC、CCR4和BIRC3。

遗传抑制BIRC3可诱导ATL细胞生长抑制,提示其可能是IRF4-NF-κB转录网络的一个重要的下游效应分子。

原始出处:

本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1738095, encodeId=be5a1e38095f6, content=<a href='/topic/show?id=4a241003557' target=_blank style='color:#2F92EE;'>#IRF4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10035, encryptionId=4a241003557, topicName=IRF4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36ed34353270, createdName=ms2536978994064944, createdTime=Fri Nov 13 20:46:00 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984326, encodeId=6a92198432673, content=<a href='/topic/show?id=7e1e9200888' target=_blank style='color:#2F92EE;'>#调控基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92008, encryptionId=7e1e9200888, topicName=调控基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236b481, createdName=anan, createdTime=Thu Sep 03 23:46:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037760, encodeId=22f5203e7608d, content=<a href='/topic/show?id=559a326941b' target=_blank style='color:#2F92EE;'>#前馈回路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32694, encryptionId=559a326941b, topicName=前馈回路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Wed Jan 06 17:46:00 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348113, encodeId=23e113481133e, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Wed Feb 05 02:46:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1738095, encodeId=be5a1e38095f6, content=<a href='/topic/show?id=4a241003557' target=_blank style='color:#2F92EE;'>#IRF4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10035, encryptionId=4a241003557, topicName=IRF4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36ed34353270, createdName=ms2536978994064944, createdTime=Fri Nov 13 20:46:00 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984326, encodeId=6a92198432673, content=<a href='/topic/show?id=7e1e9200888' target=_blank style='color:#2F92EE;'>#调控基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92008, encryptionId=7e1e9200888, topicName=调控基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236b481, createdName=anan, createdTime=Thu Sep 03 23:46:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037760, encodeId=22f5203e7608d, content=<a href='/topic/show?id=559a326941b' target=_blank style='color:#2F92EE;'>#前馈回路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32694, encryptionId=559a326941b, topicName=前馈回路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Wed Jan 06 17:46:00 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348113, encodeId=23e113481133e, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Wed Feb 05 02:46:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]
    2020-09-03 anan
  3. [GetPortalCommentsPageByObjectIdResponse(id=1738095, encodeId=be5a1e38095f6, content=<a href='/topic/show?id=4a241003557' target=_blank style='color:#2F92EE;'>#IRF4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10035, encryptionId=4a241003557, topicName=IRF4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36ed34353270, createdName=ms2536978994064944, createdTime=Fri Nov 13 20:46:00 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984326, encodeId=6a92198432673, content=<a href='/topic/show?id=7e1e9200888' target=_blank style='color:#2F92EE;'>#调控基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92008, encryptionId=7e1e9200888, topicName=调控基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236b481, createdName=anan, createdTime=Thu Sep 03 23:46:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037760, encodeId=22f5203e7608d, content=<a href='/topic/show?id=559a326941b' target=_blank style='color:#2F92EE;'>#前馈回路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32694, encryptionId=559a326941b, topicName=前馈回路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Wed Jan 06 17:46:00 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348113, encodeId=23e113481133e, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Wed Feb 05 02:46:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1738095, encodeId=be5a1e38095f6, content=<a href='/topic/show?id=4a241003557' target=_blank style='color:#2F92EE;'>#IRF4#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10035, encryptionId=4a241003557, topicName=IRF4)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36ed34353270, createdName=ms2536978994064944, createdTime=Fri Nov 13 20:46:00 CST 2020, time=2020-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1984326, encodeId=6a92198432673, content=<a href='/topic/show?id=7e1e9200888' target=_blank style='color:#2F92EE;'>#调控基因#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92008, encryptionId=7e1e9200888, topicName=调控基因)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=236b481, createdName=anan, createdTime=Thu Sep 03 23:46:00 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037760, encodeId=22f5203e7608d, content=<a href='/topic/show?id=559a326941b' target=_blank style='color:#2F92EE;'>#前馈回路#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32694, encryptionId=559a326941b, topicName=前馈回路)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Wed Jan 06 17:46:00 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1348113, encodeId=23e113481133e, content=<a href='/topic/show?id=d61b418860a' target=_blank style='color:#2F92EE;'>#基因表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41886, encryptionId=d61b418860a, topicName=基因表达)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Wed Feb 05 02:46:00 CST 2020, time=2020-02-05, status=1, ipAttribution=)]

相关资讯

Blood:PD-1抑制剂治疗导致成人T细胞白血病/淋巴瘤快速进展

免疫检查点抑制剂是治疗癌症的强有力新工具,可延长多种疾病的缓解期,包括血液恶性肿瘤,如霍奇金淋巴瘤。但在近期的一份报告中,Rauch等人发现PD-1抑制剂纳武单抗可导致成人T细胞白血病/淋巴瘤(ATLL)患者快速进展。研究人员从患者身上获得了原代细胞,以研究这种恶性进展原因。对恶性细胞的克隆、体细胞突变和基因表达的分析证实了在这些患者中PD-1阻滞后快速进展的报道,揭示了这些恶性细胞的起源,发现了